Developer docs
API playgroundTry for free, no card

Search company profiles

Gremse-IT

Full company profile

uuid000ew49

Namestring
Gremse-IT
Legal namestring
Gremse-IT GmbH
Websiteurl
gremse-it.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Gremse-IT GmbH is a privately held, founder-led software company headquartered in Aachen, Germany, with additional offices in Montreal, Canada and Yangzhou, China. Founded in 2016, the company has 11–50 employees and is focused exclusively on preclinical biomedical image analysis, serving academic imaging cores, pharmaceutical and biotech R&D teams (notably in radiopharmaceuticals and theranostics), contract research organizations, and medical device manufacturers. Its commercial traction includes deployments in 200+ institutions globally, with named customers spanning University of Missouri, University of Wisconsin, UCLA, Washington University in St. Louis, Cologne University Hospital, RayzeBio, and Charles River/Inotiv.

The company's flagship product, Imalytics Preclinical, is a GPU-accelerated, multimodal image analysis platform that supports PET, SPECT, CT, MRI, ultrasound, and optical imaging in a single workspace, with AI-assisted organ segmentation, batch processing, and pharmacokinetic/dosimetry modeling. A proprietary GFF (Grace File Format) underpins data storage with lossless compression and cryptographic hashing, and an open-source Python package (gffio) extends the platform into external ML workflows. Imalytics is compatible with 30+ preclinical imaging vendors including Bruker, Siemens, Mediso, Revvity, and SCANCO, creating broad install-base reach.

Gremse-IT monetizes through quote-based software licensing (both perpetual and time-limited subscription models with separable support contracts), complemented by three services: an AI-powered Radiopharmaceutical Biodistribution Pipeline add-on, Image Analysis as a Service (expert-reviewed quantification), and OEM Software Development for device manufacturers. Distribution is direct, via field sales, with free demos and a consultation-based sales motion targeting enterprise and institutional buyers worldwide.

Short descriptiontext

Gremse-IT provides GPU-accelerated, multimodal preclinical biomedical image analysis software (Imalytics Preclinical), serving academic imaging cores, pharmaceutical/biotech R&D groups (radiopharmaceuticals, theranostics), CROs, and medical device manufacturers across 200+ institutions globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAachen, Germany
HQ citystring
Aachen
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
preclinical imaging software, biomedical image analysis, PET/SPECT/CT quantification, AI-assisted organ segmentation, radiopharmaceutical dosimetry
Industry3 codes
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
NAICS code2 codes
  • Software Publishers513210
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Services-Prepackaged Software7372
  • Laboratory Analytical Instruments3826
Product category
Preclinical Imaging Software
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Software Licensing
TypeSubscription Recurring
Description

Imalytics Preclinical is sold as licensed software with two primary models: (1) Permanent license with limited support period, and (2) Time-limited license with support included for the contract duration. The software runs locally on Windows or MacOS systems and requires hardware-specific license activation. Additional support contracts can be purchased separately for ongoing technical assistance.

imalytics.com
2Professional Services
TypeProfessional Services
Description

Custom AI-powered biodistribution pipelines, quantitative image analysis as a service, and tailored software development for CROs, pharmaceutical companies, and device manufacturers.

imalytics.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
Pricing details2 tiers
1Permanent License
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Perpetual license with limited initial support period. Additional support can be purchased separately. Requires PC with Windows 64-bit or MacOS with at least 8GB memory.

imalytics.com
2Time-Limited License
ModelSubscriptionBilling cadenceMulti-year contract
Notes

License valid for a definite time period with support included for the duration. Support responds within 2 business days typically.

imalytics.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1Imalytics Preclinical
Description

Flagship image analysis platform for preclinical biomedical imaging supporting PET, SPECT, CT, MRI, ultrasound, and optical imaging modalities with GPU-accelerated performance and AI-assisted segmentation.

imalytics.com
+1 more record
Core offering1 text field

Gremse-IT develops and sells Imalytics Preclinical, a GPU-accelerated software platform for visualization, segmentation, and quantification of preclinical biomedical imaging data across PET, SPECT, CT, MRI, ultrasound, and optical modalities. The company complements the software with an AI-powered Radiopharmaceutical Biodistribution Pipeline, Image Analysis as a Service, and OEM/custom software development for device manufacturers and CROs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Analysis time reduced from days to minutes with AI-powered biodistribution pipeline
+3 more records
Product overview1 text field

Gremse-IT offers a unified product ecosystem centered on the Imalytics Preclinical platform for preclinical biomedical image analysis. The core platform supports multimodal imaging (PET, SPECT, CT, MRI, ultrasound, and optical) with GPU acceleration, AI-assisted segmentation, and batch processing capabilities. Three complementary service offerings surround the platform: the AI-powered Radiopharmaceutical Biodistribution Pipeline for automated organ segmentation and dosimetry; Image Analysis as a Service for expert-reviewed quantification; and OEM Software Development for tailored imaging solutions. An open-source Python extension (gffio) enables Python users to integrate Imalytics data into custom preprocessing workflows. The product portfolio serves over 200 institutions and pharmaceutical companies worldwide.

Product and service1 record
1Imalytics Preclinical
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Revvity offers the VivoQuant preclinical imaging analysis platform alongside its IVIS optical imaging systems and other molecular imaging modalities. It is a broad incumbent serving similar pharma/biotech and academic preclinical imaging customers with bundled hardware-plus-software offerings, competing head-to-head with Imalytics in PET, SPECT, CT, and optical workflows.

TypeBroad incumbent
Description

Siemens offers syngo.via and other imaging software platforms predominantly for clinical but also for preclinical research workflows. It competes as a broad incumbent with strong OEM bundling, particularly in PET/CT and SPECT where Imalytics has strong academic and pharma penetration.

3Fiji / ImageJ
TypeEmerging player
Description

Fiji (and its ImageJ base) is the de facto open-source standard for biomedical image analysis in academic labs. While narrower in nuclear imaging quantification, it remains a baseline competitor for many academic preclinical imaging cores considering Imalytics Preclinical.

TypeEmerging player
Description

3D Slicer is a widely used open-source platform for 3D medical image visualization, segmentation, and analysis with growing preclinical adoption and an active extension ecosystem. It is a partial substitute that competes most aggressively on price-sensitive academic deals, particularly for MRI/CT workflows.

5Visian Medical Imaging
TypeDirect peer
Description

Visian provides preclinical image analysis software and services similar in scope to Imalytics Preclinical, with a focus on multimodal PET, SPECT, CT, and MRI quantification. It targets the same academic imaging core and pharma/CRO buyers with comparable feature sets.

TypeDirect peer
Description

PMOD provides specialized software for quantitative PET/SPECT data analysis, kinetic modeling, and dosimetry in preclinical and clinical imaging. It directly overlaps with Imalytics Preclinical's nuclear imaging quantification, Patlak/compartmental modeling, and voxel dosimetry capabilities, serving the same pharma and academic research buyer.

TypeBroad incumbent
Description

Mediso manufactures preclinical PET/SPECT/CT scanners and supplies associated software for image reconstruction and quantification. It is both a compatible hardware partner for Imalytics and a competitor via its bundled analysis tools in multimodal preclinical imaging.

TypeDirect peer
Description

inviCRO (now part of Capsule Pharma) provides preclinical and translational imaging analysis software and services to pharma and biotech, overlapping directly with Imalytics's biodistribution, dosimetry, and quantitative imaging offerings for drug development customers.

TypeBroad incumbent
Description

Thermo Fisher's Amira/Avizo 3D visualization and analysis software is widely used in life sciences imaging, including preclinical applications. While broader in scope (materials science, clinical), it overlaps with Imalytics's 3D/4D visualization and segmentation workflows for biomedical researchers.

TypeBroad incumbent
Description

Bruker is a major preclinical imaging OEM whose ParaVision software is bundled with its MRI, PET, and microCT scanners. As both a partner (Imalytics is compatible with Bruker systems) and a competitor, Bruker represents the most significant bundled-software threat to Gremse-IT in academic and pharma preclinical imaging labs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Gremse-IT

Preclinical Imaging Softwaregremse-it.com

Gremse-IT provides GPU-accelerated, multimodal preclinical biomedical image analysis software (Imalytics Preclinical), serving academic imaging cores, pharmaceutical/biotech R&D groups (radiopharmaceuticals, theranostics), CROs, and medical device manufacturers across 200+ institutions globally.

What Gremse-IT does

Gremse-IT GmbH is a privately held, founder-led software company headquartered in Aachen, Germany, with additional offices in Montreal, Canada and Yangzhou, China. Founded in 2016, the company has 11–50 employees and is focused exclusively on preclinical biomedical image analysis, serving academic imaging cores, pharmaceutical and biotech R&D teams (notably in radiopharmaceuticals and theranostics), contract research organizations, and medical device manufacturers. Its commercial traction includes deployments in 200+ institutions globally, with named customers spanning University of Missouri, University of Wisconsin, UCLA, Washington University in St. Louis, Cologne University Hospital, RayzeBio, and Charles River/Inotiv.

The company's flagship product, Imalytics Preclinical, is a GPU-accelerated, multimodal image analysis platform that supports PET, SPECT, CT, MRI, ultrasound, and optical imaging in a single workspace, with AI-assisted organ segmentation, batch processing, and pharmacokinetic/dosimetry modeling. A proprietary GFF (Grace File Format) underpins data storage with lossless compression and cryptographic hashing, and an open-source Python package (gffio) extends the platform into external ML workflows. Imalytics is compatible with 30+ preclinical imaging vendors including Bruker, Siemens, Mediso, Revvity, and SCANCO, creating broad install-base reach.

Gremse-IT monetizes through quote-based software licensing (both perpetual and time-limited subscription models with separable support contracts), complemented by three services: an AI-powered Radiopharmaceutical Biodistribution Pipeline add-on, Image Analysis as a Service (expert-reviewed quantification), and OEM Software Development for device manufacturers. Distribution is direct, via field sales, with free demos and a consultation-based sales motion targeting enterprise and institutional buyers worldwide.

Gremse-IT firmographics

Firmographics
Name
Gremse-IT
Legal name
Gremse-IT GmbH
Website
https://gremse-it.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Gremse-IT provides GPU-accelerated, multimodal preclinical biomedical image analysis software (Imalytics Preclinical), serving academic imaging cores, pharmaceutical/biotech R&D groups (radiopharmaceuticals, theranostics), CROs, and medical device manufacturers across 200+ institutions globally.
Ownership category
akta.pro rank

Gremse-IT industry classification

Industry
Product category
Preclinical Imaging Software
NAICS
Software Publishers (513210), Computer Systems Design and Related Services (54151)
SIC
Services-Prepackaged Software (7372), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)

Keywords

  • Preclinical imaging software
  • Biomedical image analysis
  • PET/SPECT/CT quantification
  • AI-assisted organ segmentation
  • Radiopharmaceutical dosimetry

Where Gremse-IT is headquartered

Location

Headquarters

HQ city
Aachen
HQ country
Germany
HQ region
Europe

Offices3 records

Markets served

Gremse-IT business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Software Licensing: Imalytics Preclinical is sold as licensed software with two primary models: (1) Permanent license with limited support period, and (2) Time-limited license with support included for the contract duration. The software runs locally on Windows or MacOS systems and requires hardware-specific license activation. Additional support contracts can be purchased separately for ongoing technical assistance.
  2. Professional Services: Custom AI-powered biodistribution pipelines, quantitative image analysis as a service, and tailored software development for CROs, pharmaceutical companies, and device manufacturers.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractPermanent License
SubscriptionMulti-year contractTime-Limited License

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Gremse-IT product offering

Product offering

Core offering

Gremse-IT develops and sells Imalytics Preclinical, a GPU-accelerated software platform for visualization, segmentation, and quantification of preclinical biomedical imaging data across PET, SPECT, CT, MRI, ultrasound, and optical modalities. The company complements the software with an AI-powered Radiopharmaceutical Biodistribution Pipeline, Image Analysis as a Service, and OEM/custom software development for device manufacturers and CROs.

Product overview

Gremse-IT offers a unified product ecosystem centered on the Imalytics Preclinical platform for preclinical biomedical image analysis. The core platform supports multimodal imaging (PET, SPECT, CT, MRI, ultrasound, and optical) with GPU acceleration, AI-assisted segmentation, and batch processing capabilities. Three complementary service offerings surround the platform: the AI-powered Radiopharmaceutical Biodistribution Pipeline for automated organ segmentation and dosimetry; Image Analysis as a Service for expert-reviewed quantification; and OEM Software Development for tailored imaging solutions. An open-source Python extension (gffio) enables Python users to integrate Imalytics data into custom preprocessing workflows. The product portfolio serves over 200 institutions and pharmaceutical companies worldwide.

Differentiator

Problem solved

Functional benefit

Brands

  • Imalytics Preclinical: Flagship image analysis platform for preclinical biomedical imaging supporting PET, SPECT, CT, MRI, ultrasound, and optical imaging modalities with GPU-accelerated performance and AI-assisted segmentation.
  • gffio

Products and services

  • Imalytics Preclinical

Quantifiable outcome

  • Analysis time reduced from days to minutes with AI-powered biodistribution pipeline
  • +3 more outcomes

Companies that use Gremse-IT

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Gremse-IT technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature8 records

Gremse-IT partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Gremse-IT competitors and assessment

Company assessment

Broad incumbents

  • Revvity (formerly PerkinElmer): Revvity offers the VivoQuant preclinical imaging analysis platform alongside its IVIS optical imaging systems and other molecular imaging modalities. It is a broad incumbent serving similar pharma/biotech and academic preclinical imaging customers with bundled hardware-plus-software offerings, competing head-to-head with Imalytics in PET, SPECT, CT, and optical workflows.
  • Siemens Healthineers: Siemens offers syngo.via and other imaging software platforms predominantly for clinical but also for preclinical research workflows. It competes as a broad incumbent with strong OEM bundling, particularly in PET/CT and SPECT where Imalytics has strong academic and pharma penetration.
  • Mediso Medical Imaging Systems: Mediso manufactures preclinical PET/SPECT/CT scanners and supplies associated software for image reconstruction and quantification. It is both a compatible hardware partner for Imalytics and a competitor via its bundled analysis tools in multimodal preclinical imaging.
  • Thermo Fisher Scientific (Amira/Avizo): Thermo Fisher's Amira/Avizo 3D visualization and analysis software is widely used in life sciences imaging, including preclinical applications. While broader in scope (materials science, clinical), it overlaps with Imalytics's 3D/4D visualization and segmentation workflows for biomedical researchers.
  • Bruker: Bruker is a major preclinical imaging OEM whose ParaVision software is bundled with its MRI, PET, and microCT scanners. As both a partner (Imalytics is compatible with Bruker systems) and a competitor, Bruker represents the most significant bundled-software threat to Gremse-IT in academic and pharma preclinical imaging labs.

Emerging players

  • Fiji / ImageJ: Fiji (and its ImageJ base) is the de facto open-source standard for biomedical image analysis in academic labs. While narrower in nuclear imaging quantification, it remains a baseline competitor for many academic preclinical imaging cores considering Imalytics Preclinical.
  • 3D Slicer: 3D Slicer is a widely used open-source platform for 3D medical image visualization, segmentation, and analysis with growing preclinical adoption and an active extension ecosystem. It is a partial substitute that competes most aggressively on price-sensitive academic deals, particularly for MRI/CT workflows.

Direct peers

  • Visian Medical Imaging: Visian provides preclinical image analysis software and services similar in scope to Imalytics Preclinical, with a focus on multimodal PET, SPECT, CT, and MRI quantification. It targets the same academic imaging core and pharma/CRO buyers with comparable feature sets.
  • PMOD Technologies: PMOD provides specialized software for quantitative PET/SPECT data analysis, kinetic modeling, and dosimetry in preclinical and clinical imaging. It directly overlaps with Imalytics Preclinical's nuclear imaging quantification, Patlak/compartmental modeling, and voxel dosimetry capabilities, serving the same pharma and academic research buyer.
  • inviCRO (iPRECIO / Molecular Imaging): inviCRO (now part of Capsule Pharma) provides preclinical and translational imaging analysis software and services to pharma and biotech, overlapping directly with Imalytics's biodistribution, dosimetry, and quantitative imaging offerings for drug development customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Gremse-IT social profiles

Digital presence

Gremse-IT financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Gremse-IT leadership team

Management profile

Number of profiles

Profiles1 record

Gremse-IT funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Gremse-IT M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gremse-IT

What does Gremse-IT do?

Gremse-IT develops and sells Imalytics Preclinical, a GPU-accelerated software platform for visualization, segmentation, and quantification of preclinical biomedical imaging data across PET, SPECT, CT, MRI, ultrasound, and optical modalities. The company complements the software with an AI-powered Radiopharmaceutical Biodistribution Pipeline, Image Analysis as a Service, and OEM/custom software development for device manufacturers and CROs.

Is Gremse-IT a public or private company?

Gremse-IT is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Gremse-IT founded?

Gremse-IT was founded in 2016. It employs 11 to 50 people.

Where is Gremse-IT based?

Gremse-IT is headquartered in Aachen, Germany, in the Europe region.

How does Gremse-IT make money?

Two revenue lines are on record. Software Licensing is the primary driver. The others are professional Services.

Who are Gremse-IT's main competitors?

Broad incumbents on record are Revvity (formerly PerkinElmer), Siemens Healthineers, Mediso Medical Imaging Systems, Thermo Fisher Scientific (Amira/Avizo) and Bruker. Emerging players are Fiji / ImageJ and 3D Slicer. Direct peers are Visian Medical Imaging, PMOD Technologies and inviCRO (iPRECIO / Molecular Imaging).

Does Gremse-IT have an API?

No public API is recorded for Gremse-IT.

What industry is Gremse-IT in?

Gremse-IT's product category is Preclinical Imaging Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales